Arrowhead Pharmaceuticals Stock Investor Sentiment
| ARWR Stock | USD 23.29 0.49 2.06% |
Slightly above 71% of Arrowhead Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Arrowhead Pharmaceuticals suggests that many traders are alarmed. Arrowhead Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Arrowhead Pharmaceuticals. The current market sentiment, together with Arrowhead Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Arrowhead Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
29
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Arrowhead Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Arrowhead Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Arrowhead Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arrowhead daily returns and investor perception about the current price of Arrowhead Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Arrowhead Historical Sentiment
Although Arrowhead Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Arrowhead, such as negative comments on social media and news outlets, may cause fear in the market and push Arrowhead Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Arrowhead.
Arrowhead |
Arrowhead Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Arrowhead Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Arrowhead Pharmaceuticals Historical Investor Sentiment
Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with an investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arrowhead Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arrowhead Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Arrowhead Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Arrowhead Pharmaceuticals.
Far too much social signal, news, headlines, and media speculation about Arrowhead Pharmaceuticals that are available to investors today. That information is available publicly through Arrowhead media outlets and privately through word of mouth or via Arrowhead internal channels. However, regardless of the origin, that massive amount of Arrowhead data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arrowhead Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arrowhead Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arrowhead Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arrowhead Pharmaceuticals alpha.
Arrowhead Pharmaceuticals Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Arrowhead Pharmaceuticals First Quarter 2024 Earnings Misses Expectations | 02/08/2024 |
2 | Arrowhead Pharmaceuticals Initiates Phase 12a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy | 03/08/2024 |
3 | Disposition of tradable shares by Lu Hongbo of Arrowhead Pharmaceuticals subject to Rule 16b-3 | 03/15/2024 |
4 | Acquisition by Lu Hongbo of 1000 shares of Arrowhead Pharmaceuticals at 28.0 subject to Rule 16b-3 | 03/19/2024 |
5 | Acquisition by Lu Hongbo of 1000 shares of Arrowhead Pharmaceuticals at 27.5 subject to Rule 16b-3 | 03/20/2024 |
6 | Disposition of 6000 shares by Hamilton James C of Arrowhead Pharmaceuticals at 28.03 subject to Rule 16b-3 | 04/03/2024 |
7 | Mirae Asset Global Investments Co. Ltd. Lowers Position in Arrowhead Pharmaceuticals, Inc. - Defense World | 04/15/2024 |
8 | Arrowhead Pharmaceuticals Shares Up 7.5 percent - MarketBeat | 04/23/2024 |
Check out Arrowhead Pharmaceuticals Hype Analysis, Arrowhead Pharmaceuticals Correlation and Arrowhead Pharmaceuticals Performance. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (2.77) | Revenue Per Share 1.697 | Quarterly Revenue Growth (0.94) | Return On Assets (0.25) |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.